With over five decades of clinical experience, Louis B. Chaykin, MD has been a Principal Investigator with Meridien Research since 2007. He has conducted countless studies in diabetes as well as studies involving lipids, metabolic syndrome and osteoporosis. Most of all, he cares for his patients and wants to help them get well.
Why Clinical Research?
During much of his time in private practice, there were only two medications for people with diabetes—insulin and sulfonylureas. It’s only been in the last 15 years that the number of medications and therapies for people with diabetes has grown to about 13. The increase in new drugs coincides with a quickly growing population of Americans with type 2 diabetes.
According to the American Diabetes Association (ADA), over 29 million people in the US had diabetes in 2012. People with type 2 diabetes account for 90% of that population. And, over a million new cases of diabetes are reported every year. In the US, 1 in 3 adults have pre-diabetes that can become type 2 diabetes if they are unable to get regular exercise and implement a weight reduction plan. The US government and private companies are part of a major push to develop medications that treat the many people caught in this epidemic.
Benefits of Research
“Because there are a small number of endocrinologists across the country,” said Dr. Chaykin. “Only about 3 to 4 percent of people with diabetes are able to see a specialist.” In the Bradenton/Sarasota area, there are only nine endocrinologists for over a half million people. Dr. Chaykin and his experienced staff at the Meridien Research clinic in Bradenton, Florida provide a service to the community, especially for those who are unable to see a specialist for the maintenance or treatment of their diabetes.
Dr. Chaykin’s research also provides an alternative for many people in need of better medications and therapies. “Patients with diabetes can come here (Meridien Research) and become educated about their disease, and its complications, while taking part in the latest therapies or combination of therapies to improve their quality of life.”
Originally from Philadelphia, Dr. Chaykin graduated from Temple University and continued at Temple for Medical School, where he graduated at the top of his class. He completed his residency and fellowship in Endocrinology and Metabolic Disease at the University of Pennsylvania and Philadelphia Veterans Hospital.
After his residency, Dr. Chaykin entered the Air Force in 1965. He was stationed at McDill Air Force Base during the early years of the Vietnam War. Once his tour of duty was completed, he left the military and moved to Detroit to teach at Henry Ford Hospital.
He left the Michigan winters and academia behind after only a couple years in his position at Henry Ford in order to open a private practice in Miami. His successful practice and career lasted until his semi-retirement in 2007, when he moved to the Bradenton/Sarasota, Florida area to be closer to his children.
Not one to settle down, he found an opportunity with Meridien Research to continue his passion for helping people. Since he began, Dr. Chaykin has completed countless studies on diabetes, sexual dysfunction, lipids, metabolic syndrome and osteoporosis. He was also voted one of the best doctors in Bradenton for the past eight years in a row!
Currently, Dr. Chaykin lives in the Bradenton/Sarasota area with his wife of more than 50 years. He has pulled back on his volunteering hours with the ADA. It was only a few years ago that he completed three marathons and raised over $100 thousand for diabetes research. He still devotes some of his time at a local free clinic and continues to run every day.
If you or someone you know could benefit from Dr. Chaykin’s experience with diabetes, please do not hesitate to contact Meridien Research today!